Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Writing · PRO

Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data

A patient-reported outcome (PRO) is defined by the source of the report rather than by the construct measured. Once a clinician interprets or adjusts a patient’s response, the measure no longer qualifies as a PRO.

Pubrica AcademyWritten by a clinical outcomes specialist Reviewed bya biostatistician Published10 October 2026 Last checked10 October 2026 Reading time4 minutes Sources1 peer-reviewed

A Patient-Reported Outcome (PRO) is any report of the status of a patient's health condition that comes directly from the patient, without interpretation by a clinician or anyone else, as defined in the FDA's PRO guidance for industry.

Learning objectives

  • The criteria that distinguish a PRO from a clinician-reported or observer-reported outcome measure.
  • The reasons a validated PRO instrument cannot be modified informally without revalidation.
  • The effect of unplanned missing PRO data on the interpretability of a trial.

Common misconceptions

  • “Any outcome related to how a patient feels counts as a PRO, even if a clinician records their impression of it.” FDA's PRO guidance specifically requires the report to come directly from the patient, without interpretation by a clinician, caregiver or anyone else — a clinician's assessment of how a patient seems to be feeling is a clinician-reported outcome, not a PRO, even though both concern the patient's subjective state.

Defining characteristics of a PRO

FDA's guidance for industry on patient-reported outcome measures defines a PRO as any report of the status of a patient's health condition that comes directly from the patient, without interpretation of the patient's response by a clinician or anyone else1. This directness is the defining feature: the same underlying symptom, reported by the patient versus assessed by a clinician observing the patient, constitutes a PRO in the first case and a clinician-reported outcome in the second.

Constraints on modifying a validated PRO instrument

PRO instruments used to support a specific labelling claim are typically validated for that specific context of use — the population, the condition, and the concept measured. FDA's guidance treats informal modification of a validated instrument's wording, response options or administration mode as potentially invalidating the instrument for that use, since validation evidence was generated for the instrument as originally structured, not an altered version of it.

Effect of missing PRO data on interpretability

Because PRO data can only come directly from the patient, missing responses (from dropout, missed visits or incomplete questionnaires) cannot be completed by a clinician’s judgement without changing what is being measured. A trial using a PRO as a key outcome requires a pre-specified plan for handling missing PRO data, since informal imputation risks reintroducing precisely the interpretive layer that the PRO was designed to avoid.

Key points

Key points

A PRO is defined by its coming directly from the patient without interpretation, which is why a validated PRO instrument cannot be informally modified, and why missing PRO data require a pre-specified handling plan rather than clinician-judged imputation.

Practical application

Practical application

  1. Investigators should confirm that the outcome is genuinely patient-reported rather than clinician-assessed. The response should come directly from the patient, without an added layer of clinician interpretation.
  2. PRO instruments should be used exactly as validated, without informal modification. The wording, response options or administration mode of a validated instrument should not be altered without revalidation.
  3. The handling of missing PRO data should be pre-specified. The missing-data approach for PRO outcomes should be defined in the statistical analysis plan (SAP) before data collection begins.

Frequently asked questions

Only if the patient completes it directly without a clinician's interpretation; a clinician-administered quality-of-life assessment based on their own judgement of the patient is a different outcome category.

Not informally — shortening or otherwise modifying a validated instrument generally requires new validation evidence for the modified version before it can be relied upon for the same purpose.

References

  1. U.S. Food and Drug Administration (FDA). Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims, Guidance for Industry. read 10 October 2026. View FDA Guidance

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 10). Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data. Pubrica. https://pubrica.com/academy/abbreviations/pro-patient-reported-outcome/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

PRO instrument check

Intended for use when selecting and implementing a PRO measure.

[ ] Outcome confirmed as genuinely patient-reported, not clinician-interpreted
[ ] Instrument used exactly as validated, without informal modification
[ ] Missing-data handling for PRO data pre-specified in the SAP
[ ] Context of use (population, condition, concept) matches the instrument's validation evidence

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica assists in selecting and correctly implementing validated PRO instruments appropriate to the specific context of use, with a pre-specified missing-data plan.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Review of a PRO instrument and missing-data plan before trial initiation

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.